Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Pharmaceutical Prime Vendor Distribution Services

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

IL

Set-Aside

NONE

Documents

This scope was carved out of 36E79726R0034.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--Ramipril Capsules RFP

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Performs logistics and distribution of pharmaceuticals for prime contractors delivering to VA, DOD, BOP, and IHS agencies. Integrates with the VA and DOD Pharmaceutical Prime Vendor Programs to manage an uninterrupted source of supply. Utilizes pharmaceutical-grade logistics and warehousing systems. Delivers pharmaceuticals to end-user agencies via government Prime Vendor systems.

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
SLED
Purchase of Antibiotics
Solicitation # 2026-Informal-0210
The City of Pasadena Public Health Department is soliciting quotes for a one-time purchase of antibiotics to be stockpiled for post-exposure response to Category A agents, including anthrax, plague, and tularemia. The requirement consists of 30,000 tablets of Ciprofloxacin Hydrochloride (500mg/dose) and 200,000 tablets of Doxycycline Monohydrate (100mg/dose). All products must be FDA approved and comply with CDC and California Department of Public Health standards. Strict adherence to cold-chain storage and temperature-controlled guidelines is required, with the use of temperature-monitoring devices during transit and full lot-level traceability from production to delivery. The contract must be completed within the city's fiscal year ending June 30, 2027, with a required delivery lead time of four business days from the date of order to the delivery location at 1845 N Fair Oaks Ave, Pasadena, CA. Bidders must submit pricing electronically via the city's eProcurement Portal, ensuring that quoted unit prices include all delivery costs and sales tax, as no separate freight or handling fees will be accepted. The response deadline is November 4, 2026. Compliance requirements include the submission of a Unique Entity Identifier (UEI), IRS Form W-9, and various vendor questionnaires regarding equal opportunity and legal status. The procurement is subject to federal regulations, including FEMA terms and conditions, the Davis-Bacon Act for prevailing wages, and the Byrd Anti-Lobbying Amendment. Award will be based on the ability to deliver the specified antibiotics at a competitive price while meeting all regulatory, insurance, and technical specifications.
Public Health Department

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATION
Solicitation # SPE2DP-27-T-0183
This solicitation, identified as SPE2DP-27-T-0183, is a Request for Quotations for the procurement of sunscreen preparation under NSN 6505-01-657-9247. The required product is an over-the-counter topical sunscreen with an SPF of 50, containing 4.5% titanium dioxide and 4% zinc oxide. It must be sweat and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, and biodegradable. The unit of issue is a package of 24 three-ounce tubes. The product has a total shelf life of 24 months, with a minimum of 21 months remaining upon receipt by the government. Storage requirements are specified between 15 and 30 degrees Celsius in a cool, dry place. The contract specifies a delivery timeframe of five days with an original required delivery date of July 21, 2026. Delivery is FOB Destination, with shipments directed to locations including Fort Bragg, North Carolina, and North Stonington, Connecticut. Packaging must adhere to ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials, with palletization following RP001. Marking must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and payment requests. The procurement is subject to various federal regulations, including the Buy American Act and DFARS cybersecurity reporting standards. Quotes must be submitted via the DLA Internet Bid Board System. The solicitation is managed by the Medical Supply Chain Pharma FSA under the Department of Defense, with a primary point of contact at DLA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 4 days
View Details

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
Federal
6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
Solicitation # 36E79727R0007
The Department of Veterans Affairs Enterprise Procurement Office intends to award a single, unrestricted national mandatory requirements contract for an uninterrupted source of supply of Sacubitril-Valsartan Tablets. This procurement, issued under NAICS code 325412 and FAR Part 12, supports multiple federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will span a one-year base period with four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to execute necessary chargeback agreements to ensure timely delivery. The successful offeror must provide a unique eleven-digit National Drug Code (NDC) where the first five digits identify the offeror, and this must be the only label on the product. Strict packaging specifications are required for 60 and 180 count bottles, including a minimum volume of 120cc, a cylindrical body with at least a 5.75 inch circumference, and a safety cap that is either convertible or deshellable. Bottles must accommodate a 5.25 by 2 inch label with an additional 0.5 inch of space for barcodes and expiration data. Offerors who are not the manufacturer must provide a letter of commitment ensuring a sufficient source of supply. The solicitation is expected to be issued around December 18, 2026, with a tentative closing date of January 7, 2027.
Pharmaceutical Preparation Manufacturing

POSTED

7 days ago

DEADLINE

in 5 days
View Details
NAICS: 325412
Federal
6505--Imatinib Tablets
Solicitation # 36E79726R0036
The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.
Pharmaceutical Preparation Manufacturing

POSTED

13 days ago

DEADLINE

in about 22 hours
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS